The FHI Foundation was established in 1990 from the proceeds of the sale of Clinical Research International (CRI) to further the development mission of FHI 360. Since then, the FHI Foundation’s support has ranged from funding ground-breaking work in HIV and AIDS and strategic initiatives, like Integrated Development, that advance development work in the United States and globally, to stimulating new ideas and incentivizing innovations through its annual Catalyst Fund awards.

The FHI Foundation is now well positioned to broaden its impact in human development in strategic collaboration with others.

Both FHI 360 and the FHI Foundation are tax-exempt under the provisions of §501(c)(3).

FHI Foundation history

The FHI Foundation was built on a unique business model through a small, early investment by Family Health International (FHI) in a commercial venture. FHI’s experience in conducting large, complex clinical trials throughout the world enabled the organization to secure a large-scale U.S. study of lovastatin (Mevacor) with Merck & Co. Because of the size of the large trial (350 clinics enrolling over 8,000 patients), FHI formed a commercial affiliate, Clinical Research International (CRI), for implementation and became the first multinational, full-service clinical research organization. Dividends from CRI propelled FHI’s innovative HIV work and established FHI as a leader in the field. See our article in SSIR.

About FHI 360

FHI 360 is a nonprofit human development organization dedicated to improving lives in lasting ways by advancing integrated, locally driven solutions. Its staff includes experts in health, education, nutrition, environment, economic development, civil society, gender, youth, research, technology, communication and social marketing — creating a unique mix of complementary capabilities that address today’s interrelated development challenges. FHI 360 serves more than 70 countries and all U.S. states and territories.